PCN19 A COST-CONSEQUENCE ANALYSIS OF DARBEPOETIN ALFA ADMINISTERED EVERY 3 WEEKS (Q3W DA) COMPARED TO WEEKLY EPOETIN ALFA (QW EA) OR EPOETIN BETA (QW EB) IN PATIENTS WITH CHEMOTHERAPY-INDUCED ANEMIA (CIA):THE GERMAN CASE
LA Van Bellinghen, G Esposito, M Lamotte, A Braceo, A Goertz, L AnnemansVolume:
10
Year:
2007
Language:
english
DOI:
10.1016/s1098-3015(10)65177-7
File:
PDF, 75 KB
english, 2007